Ledger.Open graph →
SEC Form D · Amendment · filed October 22, 2024

Mediar Therapeutics, Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Steven E. Heuck · Boston, MAExec · DirectorSimon Sturge · Boston, MADirectorMichael Baran · Boston, MADirectorMeredith Fisher · Boston, MADirectorAndreas Jurgeit · Boston, MADirectorAnja Konig · Boston, MADirectorRahul Ballal · Boston, MAExec · DirectorCassidy Blundell · Boston, MADirectorMaina Bhaman · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗